bearish
China TMT Update-LI AUTO/Akeso/BEKE-Delay Chongqing Plant/Trial of Cadonilimab BsAb/New Home Sales
293 Views17 Jul 2023 23:11
LI: Li Auto said to postpone the construction of Chongqing plant (-);Akeso started Phase III head-to-head trial of its Cadonilimab BsAb;KE Holdings: New home sales remain weak in June
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
Top Quartile
Blue Lotus Research Institute
China growth and global non-US Internet equities
- China TMT Update-BEKE/2150HK/3690HK-Meituan Recruiting 3P Delivery Partners in Lower Tier Markets21 Jul 2023
- China TMT Update-BZ/PDD/3690/NTES/700/Douyin-PDD Launches Local Life Services Portal19 Jul 2023
- China TMT Update-BABA/VIPS/JD/PDD/3690.HK/700HK/SE/XPEV-Online Retail Sales Growth；"Arena Breakout"；18 Jul 2023
- China TMT Update-LI AUTO/Akeso/BEKE-Delay Chongqing Plant/Trial of Cadonilimab BsAb/New Home Sales17 Jul 2023
- China TMT Update-Premier's Symposium;a Summary of Meituan Vs Douyin;feedbacks of Amazon Prime Day14 Jul 2023
- China TMT Update-PDD/BABA/BEKE/LUCKIN- PDD Testing “RMB 9.9” Channel;BEKE Launching “Bei Hao Jia”13 Jul 2023
- China TMT Update July 3-ZLAB/LKNCY/002202CH/601615CH: Laekna Therapeutics IPO’ed in HK03 Jul 2023
x